Therapeutics startup Achira came out of the Manhattan woodwork with a $33 million seed round to advance simulation models used to identify the proteins and other particles that influence diseases ...

Cipla Ltd, a pharmaceutical company, announced on Friday that it will buy a 21.05 percent share in Achira Labs Pvt Ltd, a company that develops and sells point-of-care (PoC) medical test kits in ...